A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

Oral presentation on study demonstrating the ability of sotagliflozin to reduce the risk of hypoglycemic events regardless of kidney function in people with type 1 diabetesTHE WOODLANDS, Texas, June ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data ...

A large-scale cohort study published in JAMA Network Open highlights a strong connection between income levels and the risk ...

Managing diabetes during summer is not just about controlling carbohydrates or skipping desserts, fruit, and other sweets ...

Abvance Therapeutics, a biotechnology company developing next generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the presentation of new ...

Diabetic shock is a state of severe low blood sugar, known as hypoglycemia. Diabetic shock is an emergency and can lead to a diabetic coma without treatment. Hypoglycemia, or low blood sugar ...

For the nearly 40 million Americans living with diabetes, an important part of managing the disease is monitoring blood sugar ...

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize ...